Ali Ozes net worth
Quick answer
Ali Ozes's estimated net worth is $15.0M (range $10.5M – $22.5M) as of 2026. Ali Ozes is Founder at Altay Therapeutics. Altay Therapeutics valuation.
Ali Ozes is Founder at Altay Therapeutics (YC W20). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Education: Harvard University
- Region: United States of America
- Industries: Healthcare, Therapeutics
- Team size: 6
- Website: http://www.altaytherapeutics.com
Who is Ali Ozes?
Ali Ozes is a founder involved in Altay Therapeutics, which participated in Y Combinator's Winter 2020 batch.
Highlights:
- Harvard University
- Stanford University
- Y Combinator W20
About Altay Therapeutics
Altay develops small molecule drugs to treat chronic liver diseases like liver fibrosis and liver cancer. Our co-founder Dr. Osman Ozes, led the first drug development program for Esbriet (Pirfenidone), resulting in the first FDA approved therapy for lung fibrosis. Esbriet is now a $1 billion/year drug and has already made over $6 billion in revenue.
With a team that has over 70+ years of small molecule drug...
FAQ: Ali Ozes net worth and Altay Therapeutics valuation
What is Ali Ozes's net worth?
Ali Ozes's estimated net worth is $15.0M (range $10.5M – $22.5M) as of 2026. Ali Ozes is Founder at Altay Therapeutics. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Altay Therapeutics valuation?
Altay Therapeutics's estimated valuation on Entrepreneurial Check is $30.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Ali Ozes's role?
Ali Ozes is Founder at Altay Therapeutics, a Y Combinator-backed startup (batch W20).